Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging

Nucl Med Biol. 1993 May;20(4):461-7. doi: 10.1016/0969-8051(93)90077-8.

Abstract

62Cu(T1/2 = 9.8 min) is a generator-produced positron-emitting radionuclide with a half-life amenable to blood-pool imaging with PET. Three bifunctional chelates [cyclic anhydride of diethylenetriaminepentaacetic acid (cDTPAA), 6-bromoacetamidobenzyl-1,4,8,11-tetraazacyclotetradecane-N,N ',N", N"'-tetraacetic acid (BAT), and p-carboxyethylphenylglyoxal-bis-(4N-methyl-thiosemicarbazone (CE-DTS)] were conjugated to HSA and labeled with 67Cu. The labeling efficiency of 67Cu-DTS-HSA was > 90%, whereas the labeling yields of 67Cu-DTPA-HSA and 67Cu-benzyl-TETA-HSA were less than 70%. Blood clearance and biodistribution of these three 67Cu-labeled conjugates were determined in rats. Of the three 67Cu-labeled bifunctional chelate-HSA conjugates, 67Cu-benzyl-TETA-HSA remained in the blood pool the longest, achieving stable blood levels at times longer than 24 h post-injection. The 67Cu radioactivity cleared the blood within 60 min post-injection of 67Cu-DTS-HSA, and within 10 min after administration of 67Cu-DTPA-HSA, indicating the dissociation of Cu2+ from these conjugates. Copper-labeled DTS-HSA achieved stable blood concentrations for at least 30 min post-injection and was therefore evaluated as a vascular imaging agent. DTS-HSA and benzyl-TETA-HSA were labeled with 62Cu and administered to a dog for blood-pool imaging using PET. Images were nearly identical to an image taken after administration of C15O. Because of the high labeling efficiency, DTS-HSA can be labeled with 62Cu without purification, making it more practical than 62Cu-benzyl-TETA-HSA as a blood-pool imaging agent.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacokinetics
  • Copper / blood
  • Copper / chemistry
  • Copper / pharmacokinetics
  • Copper Radioisotopes*
  • Coronary Vessels / diagnostic imaging
  • Cross-Linking Reagents / chemistry
  • Cross-Linking Reagents / pharmacokinetics
  • Diagnostic Imaging / methods
  • Dogs
  • Drug Stability
  • Female
  • Heart / diagnostic imaging*
  • Heterocyclic Compounds / blood
  • Heterocyclic Compounds / pharmacokinetics
  • Male
  • Organometallic Compounds / blood*
  • Organometallic Compounds / pharmacokinetics
  • Pentetic Acid / analysis
  • Pentetic Acid / chemistry
  • Pentetic Acid / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Serum Albumin* / analysis
  • Serum Albumin* / chemistry
  • Serum Albumin* / pharmacokinetics
  • Serum Albumin, Human
  • Thiosemicarbazones / blood
  • Thiosemicarbazones / chemistry
  • Thiosemicarbazones / pharmacokinetics
  • Tissue Distribution
  • Tomography, Emission-Computed

Substances

  • Chelating Agents
  • Copper Radioisotopes
  • Cross-Linking Reagents
  • Heterocyclic Compounds
  • Organometallic Compounds
  • Serum Albumin
  • Thiosemicarbazones
  • copper acetamidobenzyl-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-serum albumin
  • Copper
  • Pentetic Acid
  • 4-carboxyethylphenylglyoxal-bis(N-methylthiosemicarbazone)
  • Serum Albumin, Human